Krieger, T., Pearson, I., Bell, J., Doherty, J., & Robbins, P. (2020). Targeted literature review on use of tumor mutational burden status and programmed cell death ligand 1 expression to predict outcomes of checkpoint inhibitor treatment. Diagn Pathol.
Chicago Style aipamenaKrieger, Tina, Isobel Pearson, Judith Bell, Jim Doherty, and Paul Robbins. "Targeted Literature Review On Use of Tumor Mutational Burden Status and Programmed Cell Death Ligand 1 Expression to Predict Outcomes of Checkpoint Inhibitor Treatment." Diagn Pathol 2020.
MLA aipamenaKrieger, Tina, et al. "Targeted Literature Review On Use of Tumor Mutational Burden Status and Programmed Cell Death Ligand 1 Expression to Predict Outcomes of Checkpoint Inhibitor Treatment." Diagn Pathol 2020.